[PDF][PDF] 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

R Erbel, V Aboyans, C Boileau… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Poziom B Dane pochodzące z jednej randomizowanej próby klinicznej lub dużych badań
nierandomizowanych Poziom C Uzgodniona opinia ekspertów i/lub dane pochodzące z …

Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?

SJ Cameron, HM Russell… - Blood, The Journal of the …, 2018 - ashpublications.org
Abdominal aortic aneurysm (AAA) is a degenerative vascular pathology resulting in
significant morbidity and mortality in older adults due to rupture and sudden death. Despite …

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular …

V Aboyans, R Bauersachs, L Mazzolai… - European Heart …, 2021 - academic.oup.com
The aim of this collaborative document is to provide an update for clinicians on best
antithrombotic strategies in patients with aortic and/or peripheral arterial diseases …

[HTML][HTML] Antithrombotic therapy in peripheral artery disease: current evidence and future directions

ME Canonico, R Piccolo, M Avvedimento… - Journal of …, 2023 - mdpi.com
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse
cardiovascular events, and those with disease in the lower extremities are at risk of major …

[HTML][HTML] Editor's Choice--European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery …

A Wanhainen, I Van Herzeele, FB Goncalves… - European Journal of …, 2024 - Elsevier
Abstract Objective The European Society for Vascular Surgery (ESVS) has developed
clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta …

The American Association for the Surgery of Trauma PROspective Observational Vascular Injury Treatment (PROOVIT) registry: multicenter data on modern vascular …

JJ DuBose, SA Savage, TC Fabian… - Journal of Trauma …, 2015 - journals.lww.com
BACKGROUND There is a need for a prospective registry designed to capture trauma-
specific, in-hospital, and long-term outcomes related to vascular injury. METHODS The …

[HTML][HTML] Selective intra-procedural AAA sac embolization during EVAR reduces the rate of type II endoleak

C Mascoli, A Freyrie, M Gargiulo, E Gallitto… - European Journal of …, 2016 - Elsevier
Objective The pre-treatment presence of at least six efferent patent vessels (EPV) from the
AAA sac and/or AAA thrombus volume ratio (VR%)< 40% are considered to be positive …

[HTML][HTML] Antithrombotic therapy for aortic aneurysms: a systematic review and meta-analysis

KHF Wong, P Zlatanovic, DC Bosanquet… - European Journal of …, 2022 - Elsevier
Objectives The role of antithrombotic therapy in the management of aortic and peripheral
aneurysms is unclear. This systematic review and meta-analysis aimed to assess the impact …

[HTML][HTML] The fate of endoleaks after endovascular aneurysm repair and the impact of oral anticoagulation on their persistence

TR Flohr, R Snow, F Aziz - Journal of Vascular Surgery, 2021 - Elsevier
Background The impact of anticoagulation on late endoleaks after endovascular aneurysm
repair (EVAR) is unclear despite multiple investigators studying the relationship. The …

[HTML][HTML] Long-term anticoagulation is associated with type II endoleaks and failure of sac regression after endovascular aneurysm repair

DS Kong, MD Balceniuk, D Mix, JL Ellis… - Journal of Vascular …, 2022 - Elsevier
Objective Within the context of endovascular aneurysm repair (EVAR), the role of
anticoagulation therapy on endoleak development and subsequent reintervention is unclear …